| Sources | Names Used |
|---|---|
| CTRPv2 | 16-beta-bromoandrosterone |
| PharmacoGx | 16-beta-bromoandrosterone |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6orf118 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | GTF3A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | GSDMA | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | DIS3L2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | FANCC | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | SMIM10 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | RAB18 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | RBM26 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | SOX11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | CXorf51A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
